Andrew Leger, Phd Email & Phone Number
Who is Andrew Leger, Phd? Overview
A concise factual answer block for searchers comparing this professional profile.
Andrew Leger, Phd is listed as Executive Director and Head of US BD at QL Biopharmaceutical Co, Ltd, based in Boston, Massachusetts, United States. AeroLeads shows a matched LinkedIn profile for Andrew Leger, Phd.
Andrew Leger, Phd previously worked as Venture Partner at Bioluminescence Ventures and Head Of US Business Development at Ferrer. Andrew Leger, Phd holds Post-Doctoral Research In Translational Hematology from Tufts University School Of Medicine.
Email format at QL Biopharmaceutical Co, Ltd
This section adds company-level context without repeating Andrew Leger, Phd's masked contact details.
Review company-level records connected to Andrew Leger, Phd before choosing the right outreach path.
About Andrew Leger, Phd
Experienced scientist & business development hybrid with a focus on addressing unmet medical need in patients with rare diseases. Foundational roots in preclinical drug development; currently manage business development activities in specialty disease areas. I bring those skills together to coordinate innovation in rare metabolic, hematologic, pulmonary & neurologic disorders. Subject matter expert in RNA targeting in drug development. Author h-index: 14
Andrew Leger, Phd's current company
Company context helps verify the profile and gives searchers a useful next step.
Andrew Leger, Phd work experience
A career timeline built from the work history available for this profile.
Venture Partner
Current
Head Of Us Business Development
Senior Director Of Business Development
Director Of Strategy & Business Development
Neuromuscular, Hematologic, Metabolic, & Pulmonary Diseases
Associate Director, Search & Evaluation, Business Development
Pulmonary DisordersMetabolic DiseasesHematologic DisordersExploratory Disease Areas
Manager, Strategy & Business Development
Managed search & evaluation, triage, due diligence, and licensing efforts pertaining to rare neurologic, hematologic and metabolic disorders.
Senior Scientist, Rare Cardiovascular, Neuromuscular & Metabolic Storage Diseases
Andrew Leger, Phd education
Post-Doctoral Research In Translational Hematology
Phd, Biochemistry
Ba, Molecular And Cell Biology
Frequently asked questions about Andrew Leger, Phd
Quick answers generated from the profile data available on this page.
What company does Andrew Leger, Phd work for?
Andrew Leger, Phd works for QL Biopharmaceutical Co, Ltd.
What is Andrew Leger, Phd's role at QL Biopharmaceutical Co, Ltd?
Andrew Leger, Phd is listed as Executive Director and Head of US BD at QL Biopharmaceutical Co, Ltd.
Where is Andrew Leger, Phd based?
Andrew Leger, Phd is based in Boston, Massachusetts, United States while working with QL Biopharmaceutical Co, Ltd.
What companies has Andrew Leger, Phd worked for?
Andrew Leger, Phd has worked for Ql Biopharmaceutical Co, Ltd, Bioluminescence Ventures, Ferrer, Cambridge Health Alliance, and Acceleron Pharma.
How can I contact Andrew Leger, Phd?
You can use AeroLeads to view verified contact signals for Andrew Leger, Phd at QL Biopharmaceutical Co, Ltd, including work email, phone, and LinkedIn data when available.
What schools did Andrew Leger, Phd attend?
Andrew Leger, Phd holds Post-Doctoral Research In Translational Hematology from Tufts University School Of Medicine.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial